Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
CARDIAC RESYNCHRONIZATION THERAPY WITH BIVENTRICULAR PACING OR LEFT BUNDLE BRANCH PACING: A PROSPECTIVE REGISTRY
Anno:
2025
Background: Cardiac resynchronization therapy (CRT) with biventricular pacing (BiVP) is an established treatment for heart failure (HF) with reduced ejection fraction (HFrEF) and wide QRS complexes, is effective in improving outcomes in patients who develop HF as a consequence of right ventricular pacing, and is indicated for patients with…
Leggi di più
DISCHARGE MEDICAL TREATMENT IMPLEMENTATION IN PATIENTS ADMITTED FOR AHF: PRELIMINARY DATA FROM THE BRING-UP3 HF STUDY
Anno:
2025
Background: Recent ESC guidelines introduced a new treatment paradigm for HFrEF, with a novel four pillar therapeutic approach comprising ACE-I/ARBs/ARNIs, Beta-blockers, MRAs, and SGLT2i. Furthermore, these guidelines for the first time give a Class IA recommendation for Empagliflozin and Dapagliflozin in HFmrEF and HFpEF. Evaluation of transferability of RCTs…
Leggi di più
A CASE OF FULMINANT MYOCARDITIS: THE IMPORTANCE OF EVERY DETAIL FOR EARLY TREATMENT. THE ECG AS A KEY TOOL IN EARLY DIAGNOSIS AND PROGNOSTIC STRATIFICATION
Anno:
2025
We report the case of a 67-year-old male who presented to a spoke emergency department with marked asthenia and dyspnea following an episode of acute gastroenteritis. Upon triage, the patient was assigned a red code due to hypotension and signs of hypoperfusion. Initial arterial blood gas analysis revealed metabolic…
Leggi di più
Acute heart failure due to very severe anemia. An infrequent presentation.
Anno:
2025
Anemia is a common comorbidity in patients with heart failure (HF). Less frequently anemia is the primary cause of HF and acute HF as the first manifestation of low hemoglobin levels is rarely described.  A 26 year old women, affected by mild eating disorder (BMI 18.4 Kg/mq), presented to the ED…
Leggi di più
Telemedicine interventions on Heart Failure dyad: a scoping review protocol
Anno:
2025
INTRODUCTION:  Heart failure (HF) is a chronic condition with high morbidity and mortality, affecting over 64 million people worldwide. Aging populations and comorbidities increase reliance on informal caregivers (ICs), who play a vital role in HF management. Effective HF care should prioritize the dyad, addressing perspective differences, fostering collaboration,…
Leggi di più
EFFECT OF DAPAGLIFLOZIN ON LEFT VENTRICULAR REVERSE REMODELING IN MEDIUM AND SHORT-TERM, CORRELATED WITH BASAL FUNCTIONAL CAPACITY.
Anno:
2025
Aims: Dapagliflozin, a sodium-glucose cotransporter-2inhibitor (SGLT2) is approved for the treatment of heart failure (HF) regardless of ejection fraction. The aim of our study is to evaluate the effects of dapagliflozin in the medium and short-term on left ventricular reverse remodeling, correlating the possible improvement with the basal functional…
Leggi di più
Clinical Outcomes of Axillary-Implanted Impella 5.0/5.5 for Ischemic Cardiogenic Shock: A Retrospective Single-Center Cohort Preliminary Analysis
Anno:
2025
Background: cardiogenic shock (CS) remains a major complication of acute myocardial infarction (AMI), contributing significantly to morbidity and mortality. Temporary mechanical circulatory support (t-MCS) has gained prominence in CS management, also serving as a bridge during high-risk percutaneous coronary interventions (PCI). While the DanGer Shock Trial demonstrated the superiority of…
Leggi di più
Relationship between diuretic therapy, sodium intake, urine sodium levels, and plasmatic levels of Renin, Aldosterone, Copeptin and NT-proBNP in patients in NYHA III-IV class.
Anno:
2025
Hyponatremia, the activation of the Renin- Angiotensin- Aldosterone System (RAAS) and the Ariginine-Vasopressin (AVP) are negative prognostic factors in patients with Heart Failure (HF). Data on the relationship between these variables and Neurohormonal activation are limited, in particular for what concerns the AVP. We studied the sodium balance, the changes…
Leggi di più
PERIPHERAL DECONGESTION WITH FUROSEMIDE IN PATIENTS WITH ACUTE HEART FAILURE IS ASSOCIATED TO REDUCTION IN HIGH-SENSITIVE C-REACTIVE PROTEIN
Anno:
2025
BACKGROUND the relationship between congestion and inflammation in heart failure is still challenging. Despite the literature, there is no definite data on the complex relationship between the two entities. AIMS We evaluated the relationship between peripheral and systemic inflammation before and after diuretic decongestion in patients with acute heart…
Leggi di più
IMPACT OF INTERMITTENT LEVOSIMENDAN INFUSIONS ON HEART TRANSPLANTATION
Anno:
2025
INTRODUCTION While Heart transplantation (HTx) remains the gold standard treatment for Advanced heart failure (AHF), the short donor availability prolongs the risk of long awaiting times, favoring the rate of re-hospitalization and development of end-organ damage and pulmonary artery hypertension, conditions worsening post transplantation outcomes.  Intermittent Levosimendan infusions (ILIs)…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram